Open access
1,049
Views
0
CrossRef citations to date
0
Altmetric
Research Article
Adequate effectiveness of ribociclib plus letrozole or fulvestrant in patients with advanced or metastatic hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer treated in routine Bulgarian clinical practice
Manoela Manovaa Department of Organization and Economics of Pharmacy, Faculty of Pharmacy, Medical University of Sofia, Sofia, Bulgaria;b National Council on Prices and Reimbursement of Medicinal Products, Sofia, BulgariaView further author information
, Jeliazko Arabadjievc Medical oncology, University Hospital Acibadem City Clinic Tokuda, Sofia, BulgariaView further author information
, Radoslav Mangaldzhievd Specialized Hospital for Active Treatment of Oncological Diseases Ltd, Sofia, BulgariaView further author information
, Assen Dudove Acibadem City Clinic Mladost Hospital, Sofia, BulgariaView further author information
, Daniel Penchevf Sqilline, Sofia, BulgariaView further author information
, Margit Hemetsbergerg Hemetsberger Medical Services, Vienna, AustriaView further author information
, Arkadi Sharkovh Department of Communication, Faculty of Journalism, Sofia University ‘St. Kliment Ohridski’, Sofia, BulgariaView further author information
, Boryana Zidarovab National Council on Prices and Reimbursement of Medicinal Products, Sofia, BulgariaView further author information
, Dimitrina Apostolovab National Council on Prices and Reimbursement of Medicinal Products, Sofia, BulgariaView further author information
, Maria Vasilevab National Council on Prices and Reimbursement of Medicinal Products, Sofia, BulgariaView further author information
, Silvia Terezovab National Council on Prices and Reimbursement of Medicinal Products, Sofia, BulgariaView further author information
, Mila Vlaskovskab National Council on Prices and Reimbursement of Medicinal Products, Sofia, BulgariaView further author information
& Alexandra Savovaa Department of Organization and Economics of Pharmacy, Faculty of Pharmacy, Medical University of Sofia, Sofia, Bulgaria;b National Council on Prices and Reimbursement of Medicinal Products, Sofia, BulgariaCorrespondence[email protected]
View further author information
show allView further author information
Article: 2268753
|
Received 14 Aug 2023, Accepted 04 Oct 2023, Published online: 19 Oct 2023
Reprints and Permissions
This is an open access article distributed under the terms of the Creative Commons CC BY license, which permits unrestricted use, distribution, reproduction in any medium, provided the original work is properly cited.
You are not required to obtain permission to reuse this article in part or whole.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.